Proteomic Differences in Normal and Glaucomatous Optic Nerve
About the Research Project
Program
Award Type
Standard
Award Amount
$35,000
Active Dates
April 01, 2004 - March 31, 2005
Grant ID
G2004047
Summary
The mechanism by which the optic nerve undergoes structural and functional damage in glaucoma is poorly understood. Dr. Bhattacharya’s goal is to determine the differential protein profile between normal and glaucomatous optic nerves using mass spectrometry and protein modifications. These protein changes will be studied using Western analyses and mass spectrometry. It is hoped that the identification of proteins and protein modifications may serve as markers for individuals predisposed to an increased risk of developing glaucoma. This information should provide insight into the pathologic mechanisms associated with glaucoma, and could help identify possible new drug targets for glaucoma therapy.
Grantee institution at the time of this grant: Cleveland Clinic Foundation
Related Grants
National Glaucoma Research
Exploring Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Qi Cui, MD, PhD
Current Organization
University of Pennsylvania, Perelman School of Medicine
Exploring Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Qi Cui, MD, PhD
Current Organization
University of Pennsylvania, Perelman School of Medicine
National Glaucoma Research
Using AI to Detect Loss of Connections Between Neural Cells in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Luca Della Santina, PhD, PharmD
Current Organization
University of Houston
Using AI to Detect Loss of Connections Between Neural Cells in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Luca Della Santina, PhD, PharmD
Current Organization
University of Houston
National Glaucoma Research
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet